We are live on
!
Find out more
Vanguard Portfolio Management Portfolio holdings
AUM
$2.22T
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.22T
AUM Growth
+$305B
(+16%)
Cap. Flow
+$19.5B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
21.57%
Holding
3,286
New
192
Increased
2,077
Reduced
864
Closed
145
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.74B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.66B |
| 3 |
NVIDIA
NVDA
|
+$1.58B |
| 4 |
Micron Technology
MU
|
+$1.23B |
| 5 |
Devon Energy
DVN
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.45B |
| 2 |
Seagate
STX
|
+$2.36B |
| 3 |
Western Digital
WDC
|
+$1.98B |
| 4 |
Honeywell
HON
|
+$1.74B |
| 5 |
Corning
GLW
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Financials | 11.67% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 9.73% |
| 5 | Consumer Discretionary | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2526
Orthofix Medical
OFIX
$367M
| $3.7M | ﹤0.01% |
404,839
+8,271
| +2% | +$91.2K |
2026 Q1
1 quarter
|
|
2527
Beyond Meat
BYND
$133M
| $3.69M | ﹤0.01% |
163,869
-85,241
| -34% | -$1.99M |
2026 Q1
1 quarter
|
|
2528
Mayville Engineering Co
MEC
$389M
| $3.68M | ﹤0.01% |
98,263
+22,360
| +29% | +$598K |
2026 Q1
1 quarter
|
|
|
JCAP
2529
Jefferson Capital
JCAP
$1.15B
| $3.67M | ﹤0.01% |
188,704
+26,825
| +17% | +$500K |
2026 Q1
1 quarter
|
|
2530
eGain
EGAN
$139M
| $3.67M | ﹤0.01% |
582,492
+8,116
| +1% | +$59.5K |
2026 Q1
1 quarter
|
|
2531
Bowman Consulting
BWMN
$710M
| $3.66M | ﹤0.01% |
125,172
+18,237
| +17% | +$574K |
2026 Q1
1 quarter
|
|
2532
Design Therapeutics
DSGN
$719M
| $3.64M | ﹤0.01% |
251,442
+112,877
| +81% | +$1.41M |
2026 Q1
1 quarter
|
|
2533
Repay Holdings
RPAY
$321M
| $3.62M | ﹤0.01% |
862,407
+104,420
| +14% | +$363K |
2026 Q1
1 quarter
|
|
2534
Digimarc Corp
DMRC
$141M
| $3.61M | ﹤0.01% |
438,768
+20,464
| +5% | +$192K |
2026 Q1
1 quarter
|
|
2535
Greenlight Captial
GLRE
$489M
| $3.6M | ﹤0.01% |
222,742
+25,898
| +13% | +$445K |
2026 Q1
1 quarter
|
|
2536
Embecta
EMBC
$326M
| $3.58M | ﹤0.01% |
1,098,389
-439,568
| -29% | -$2.4M |
2026 Q1
1 quarter
|
|
|
URG
2537
Ur-Energy
URG
$402M
| $3.58M | ﹤0.01% |
+2,629,239
| New | +$4.29M |
2026 Q2
0 quarters
|
|
2538
Electromed
ELMD
$230M
| $3.57M | ﹤0.01% |
84,297
+5,960
| +8% | +$191K |
2026 Q1
1 quarter
|
|
2539
Safe Bulkers
SB
$1B
| $3.56M | ﹤0.01% |
564,396
+112,939
| +25% | +$755K |
2026 Q1
1 quarter
|
|
2540
Prime Medicine
PRME
$649M
| $3.55M | ﹤0.01% |
961,826
+99,622
| +12% | +$331K |
2026 Q1
1 quarter
|
|
2541
Ibotta
IBTA
$872M
| $3.54M | ﹤0.01% |
103,626
-19,698
| -16% | -$657K |
2026 Q1
1 quarter
|
|
2542
inTEST
INTT
$185M
| $3.52M | ﹤0.01% |
193,534
+100,142
| +107% | +$1.7M |
2026 Q1
1 quarter
|
|
2543
Achieve Life Sciences
ACHV
$741M
| $3.51M | ﹤0.01% |
+537,596
| New | +$2.56M |
2026 Q2
0 quarters
|
|
2544
HBT Financial
HBT
$1.29B
| $3.5M | ﹤0.01% |
109,524
+43,855
| +67% | +$1.26M |
2026 Q1
1 quarter
|
|
2545
Neuropace
NPCE
$425M
| $3.5M | ﹤0.01% |
220,371
+32,942
| +18% | +$530K |
2026 Q1
1 quarter
|
|
2546
Colony Bankcorp
CBAN
$431M
| $3.5M | ﹤0.01% |
174,116
+55,180
| +46% | +$1.12M |
2026 Q1
1 quarter
|
|
2547
Tiptree Inc
TIPT
$646M
| $3.48M | ﹤0.01% |
194,435
-30,133
| -13% | -$521K |
2026 Q1
1 quarter
|
|
2548
ClearPoint Neuro
CLPT
$320M
| $3.47M | ﹤0.01% |
194,584
-90,225
| -32% | -$1.13M |
2026 Q1
1 quarter
|
|
2549
Falcon's Beyond
FBYD
$427M
| $3.47M | ﹤0.01% |
193,538
+90,712
| +88% | +$1.29M |
2026 Q1
1 quarter
|
|
|
MPLT
2550
MapLight Therapeutics
MPLT
$509M
| $3.47M | ﹤0.01% |
96,761
-15,843
| -14% | -$456K |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Portfolio Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Portfolio Management held 3,286 positions worth $2.22T, up 16% from $1.91T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Vanguard Portfolio Management's Q2 2026 filing shows 192 new, 2,077 increased, 864 reduced and 145 closed positions. Its largest new stake was SpaceX: 10,225,389 shares worth $1.75B. The largest sale was Marvell Technology, an estimated $2.45B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Vanguard Portfolio Management's largest Q2 2026 buy was SpaceX: 10,225,389 shares worth $1.75B.
- Vanguard Portfolio Management added most to NVIDIA in Q2 2026, an estimated $1.58B increase.
- Vanguard Portfolio Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.45B.
- Vanguard Portfolio Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.3B.
- Vanguard Portfolio Management's ten largest holdings make up 22% of its $2.22T portfolio in Q2 2026.
- Vanguard Portfolio Management opened 192 new positions and closed 145 in Q2 2026.
- Vanguard Portfolio Management's portfolio value rose 16% quarter-over-quarter to $2.22T.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.